Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Clinical trial NCT04260022 · RECRUITING

Trial details

NCT number: NCT04260022
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic Myeloid Leukemia Chronic Myeloid Leukemia Philadelphia Positive Acute Lymphoblastic Leukemia B Cell Precursor Type Acute Leukemia

Start date: 2020-01-09
Primary completion: 2029-12-27
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.